Associated Papers
Detection of PRKAR1A gene mutations in sporadic cardiac myxomas: a study of 24 cases.
Bekers E et al.
Virchows Archiv : an International Journal of Pathology, 2025
PRKC Fusion Melanocytic Tumors, a Subgroup of Melanocytic Tumors More Closely Aligned to Blue Nevi Than to PRKAR1A-inactivated Pigmented Epithelioid Melanocytomas.
Patel P et al.
The American Journal of Surgical Pathology, 2024
Carney complex predisposes to breast cancer: prospective study of 50 women.
Vaduva P et al.
European Journal of Endocrinology, 2024
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs.
Williams EA et al.
Neuro-oncology, 2023
Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability.
Colombo C et al.
Thyroid : Official Journal of the American Thyroid Association, 2019
Recurrent somatic mutations of PRKAR1A in isolated cardiac myxoma.
He J et al.
Oncotarget, 2017
Consistent copy number changes and recurrent PRKAR1A mutations distinguish Melanotic Schwannomas from Melanomas: SNP-array and next generation sequencing analysis.
Wang L et al.
Genes, Chromosomes & Cancer, 2015
Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update.
Horvath A et al.
Human Mutation, 2010
Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.
Bertherat J et al.
The Journal of Clinical Endocrinology and Metabolism, 2009
Edgetic perturbation models of human inherited disorders.
Zhong Q et al.
Molecular Systems Biology, 2009
Heterogeneity of skin manifestations in patients with Carney complex.
Mateus C et al.
Journal of the American Academy of Dermatology, 2008
PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes.
Robinson-White AJ et al.
Cancer Research, 2006
PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.
Robinson-White A et al.
The Journal of Clinical Endocrinology and Metabolism, 2006
Frequent protein kinase A regulatory subunit A1 mutations but no GNAS mutations as potential driver in sporadic cardiac myxomas.
Zimpfer A et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology, 0